Compare ZYME & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | PRDO |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | 2017 | N/A |
| Metric | ZYME | PRDO |
|---|---|---|
| Price | $25.80 | $28.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $28.50 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 1.8M | 841.9K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ 17.26 |
| EPS | N/A | ★ 2.33 |
| Revenue | $134,481,000.00 | ★ $810,888,000.00 |
| Revenue This Year | $64.45 | $26.43 |
| Revenue Next Year | $67.04 | $3.65 |
| P/E Ratio | ★ N/A | $12.11 |
| Revenue Growth | ★ 116.21 | 24.23 |
| 52 Week Low | $9.03 | $23.87 |
| 52 Week High | $28.49 | $38.03 |
| Indicator | ZYME | PRDO |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 34.23 |
| Support Level | $24.83 | $27.56 |
| Resistance Level | $27.49 | $28.59 |
| Average True Range (ATR) | 1.32 | 0.90 |
| MACD | -0.03 | 0.17 |
| Stochastic Oscillator | 60.00 | 45.21 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.